11:00 AM EDT, 05/28/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were tracking lower late Wednesday morning, declining 0.93% to 1,450.69 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biotech firm Evaxion ( EVAX ) and furniture maker Natuzzi (NTZ), which advanced 14% and 11% respectively. They were followed by biopharmaceutical company Genfit ( GNFT ) and internet browser company Opera (OPRA), which rose 1.9% and 1.7% respectively.

The decliners from continental Europe were led by Spanish lender Banco Bilbao Vizcaya Argentaria ( BBVA ) and pharmaceutical company Novo Nordisk ( NVO ) , which fell 2.1% and 1.8% respectively. They were followed by Dutch financial services company ING (ING) and petroleum refiner Equinor ( EQNR ) , which were down 1.5% and 1.3% respectively.

From the UK and Ireland, the gainers were led by biotech firm Autolus Therapeutics ( AUTL ) and biopharmaceutical company Bicycle Therapeutics ( BCYC ) , which climbed 4.5% and 4.3% respectively. They were followed by biopharmaceutical companies Amarin ( AMRN ) and Adaptimmune Therapeutics ( ADAP ) , which advanced 1.9% and 1.4% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Biodexa Pharmaceuticals ( BDRX ) and NuCana ( NCNA ) , which dropped 6.1% and 2.9% respectively. They were followed by biotech firm Trinity Biotech ( TRIB ) and utilities company National Grid ( NGG ) , which lost 2.7% and 2.4% respectively.